HRES 719 is a House resolution honoring Charles "Charlie" James Kirk, the founder of Turning Point USA who was assassinated on September 10, 2025. The resolution condemns his assassination and all political violence, extends condolences to his family, and calls on Americans to reject violence while promoting civil discourse. It specifically recognizes Kirk's legacy as a defender of constitutional principles and his role in inspiring youth through free speech and faith-based civic engagement. As a commemorative resolution, it does not enact policy changes but formally expresses the House's stance on honoring his life and legacy.
HR 5521, the Peace Corps Volunteers Congressional Gold Medal Act of 2025, authorizes a single Congressional Gold Medal to be awarded to the Peace Corps organization. The medal recognizes all volunteers who served between August 1961 and December 2026, commemorating their 65-year contributions to global development and international relations. The award, to be presented by September 22, 2026, will be displayed at Peace Corps headquarters and other relevant locations. This symbolic honor acknowledges volunteers' work in sectors like education, health, and community development across 140+ countries.
This bill authorizes the posthumous presentation of a Congressional Gold Medal to Welles Remy Crowther, a volunteer firefighter and equities trader who died saving others during the September 11, 2001, attacks. The medal, designed by the Treasury Secretary, will be given to Crowther’s mother, Alison Crowther, following a formal presentation by congressional leaders. The bill also permits the U.S. Mint to sell bronze duplicates of the medal at cost to cover production expenses. It is a purely commemorative measure with no legislative or regulatory impact.
HR 5526, the Biosimilar Red Tape Elimination Act, streamlines the U.S. Food and Drug Administration’s (FDA) process for approving biosimilar drugs that can be used interchangeably with brand-name biologic medications. It establishes a 60-day transition period after enactment to clarify when biosimilars are deemed "interchangeable" with reference drugs, preserving existing exclusivity periods for products licensed before the law’s passage. This affects pharmaceutical manufacturers developing biosimilars, the FDA (which must update its guidance within 18 months), and healthcare systems seeking lower-cost treatment options. The bill removes redundant language from existing laws and ensures the FDA’s approval standards for biosimilars remain unchanged, focusing on regulatory clarity rather than altering drug safety or efficacy requirements.
The Veteran Service Recognition Act of 2025 requires the Departments of Defense, Homeland Security, and Veterans Affairs to study noncitizen veterans removed from the U.S. between 1990 and 2025, including their service records and reasons they were denied benefits. It creates a system to identify noncitizen veterans before removal proceedings begin and establishes a Military Family Immigration Advisory Committee to review cases and recommend against removal for veterans. The bill also creates a program to streamline citizenship for noncitizen service members, allows adjustment of status for certain removed veterans, and modifies immigration requirements for family members of service members. These provisions directly affect noncitizen veterans, active duty service members, and their family members who are not U.S. citizens. The law aims to ensure veterans' service is properly recognized in immigration proceedings and to facilitate their path to citizenship.
This bill requires the Secretary of Defense to restore access to all curricula, books, and learning materials previously available at Department of Defense Education Activity (DODEA) schools by 30 days after enactment, and prohibits new restrictions until the 2026-2027 school year. It adds new procedural requirements for future directives affecting DODEA schools, mandating advisory committee reviews and congressional notice before changes to curricula or materials. The bill also nullifies specific executive orders (including those restricting "radical indoctrination" or "gender ideology") that impacted DODEA schools and directs a study on creating an independent body to oversee DODEA curricula. It directly affects military-connected students and schools operated by the Department of Defense Education Activity.
The POJA Act of 2025 amends the Age Discrimination in Employment Act to explicitly prohibit age discrimination against job applicants, not just current employees. It directly affects job seekers aged 40 and older who face bias during hiring. The bill requires the Equal Employment Opportunity Commission to conduct a study within one year of enactment, counting age discrimination claims filed since 2015 (including closed cases), and issue a public report with prevention recommendations for employers. This study aims to address gaps in protecting applicants during the hiring process.
This bill creates a pathway to permanent residency for certain college graduates who entered the U.S. as children under specific nonimmigrant visa categories (excluding H-1B, L-1, etc.). To qualify, applicants must have been lawfully present for 10 years total (including 8 years as a dependent child), graduated from a U.S. college, and not be inadmissible. It also changes how "child status" is determined for immigration purposes - using specific dates instead of age to prevent "age-outs" for dependents of long-term visa holders - and preserves priority dates for family members. These changes apply to individuals who entered the U.S. before age 21 and maintained lawful status under qualifying visas.
This bill requires health plans and insurers to create a clear, timely process for patients or doctors to request exceptions when step therapy protocols (which force patients to try cheaper drugs first) might harm them. It mandates approval for exceptions in six specific cases, such as when prior treatments failed, delaying care risks severe harm, or the required drug causes adverse reactions. Plans must respond within 72 hours (24 hours for emergencies) and cover the requested drug for at least one year if approved. Additionally, health plans must report annual data on exception requests, approvals, denials, and reasons to the government for transparency.
This bill prohibits U.S. courts from enforcing judgments based on Shari'a or any foreign law if they conflict with constitutional rights, particularly in family law cases like divorce, child custody, or inheritance. It requires courts to apply only U.S. law when foreign legal systems would violate fundamental rights such as due process, equal protection, or freedom from coercion. Contracts may still reference foreign law, but enforcement is blocked if it infringes constitutional protections. The law aims to ensure all court decisions comply with U.S. constitutional standards nationwide.
The HEADACHE Act establishes a National Headache Disorders Initiative (NHDI) under the Department of Health and Human Services to address conditions like migraines, cluster headaches, and other headache disorders affecting vulnerable groups including children, pregnant women, and older adults. It creates an Advisory Council with patient advocates, healthcare providers, and federal agency representatives to guide research, improve diagnosis protocols, and reduce disparities in care. The bill requires federal agencies to share headache-related data and mandates an annual congressional report evaluating progress, disparities across demographics, and recommendations for better access to treatment and stigma reduction, with the initiative set to expire after five years.
The Algorithmic Accountability Act of 2025 requires companies that deploy complex AI systems making significant decisions (such as those affecting education, employment, healthcare, or financial services) to conduct impact assessments and submit annual reports to the Federal Trade Commission. It applies to companies with over $50 million in annual revenue or those handling information about more than 1 million consumers. Companies must assess potential negative impacts on consumers, including bias, privacy risks, and fairness concerns, and document their findings. The FTC will maintain a public repository of anonymized information from these reports to inform consumers and researchers about how AI systems are being used.
